1) hsa-miR-100-3p |
Alleviates neurodegeneration and activation of microglia (Li et al., 2019) |
2) hsa-miR-26b-5p |
Regulates microglial inflammatory response by targeting IL-6 after brain injury (Kang et al., 2018). |
3) hsa-let-7c-5p |
Inhibits microglial activation and alleviates neuroinflammation (Li et al., 2018). |
4) hsa-miR-335-5p |
Reduces neurodegeneration after brain injury (Liu et al., 2015). |
5) hsa-miR-423-3p |
Exerts antiapoptotic effects by inhibiting caspase-6 (Li et al., 2014) |
6) has-let-7i-5p |
Protects brain microvascular endothelial cells against oxygen glucose deprivation by decreasing toll-like receptor 4 expression (Xiang et al., 2017). |
7) hsa-miR-409-3p |
Promotes microglial migration and activation (Hu et al. 2021) |
8) hsa-let-7g-5p |
Reduces the production of proinflammatory cytokines and repairs leaky blood-brain barrier after brain injury (Rom et al. 2015; Bernstein and Rom, 2020). |
9) hsa-miR-494-3p |
Reduces neurodegeneration by inhibiting histone deacetylase 3 after brain injury (Zhao et al., 2019) |
10) hsa-miR-654-3p |
Regulates macrophage migration inhibitor factor (MIF), inhibits the phosphorylation of ERK and AKT and reduces downstream inflammatory cytokine production (Tu et al., 2019). |
11) hsa-miR-10b-5p |
Regulates brain-derived neurotrophic factor expression (Varendi et al., 2014). |
12) hsa-miR-320a |
Regulates reactive astrocyte-mediated neuronal damage by regulating ATP release (Fatima et al., 2017). |
13) hsa-miR-152-3p |
Protects neurons from oxygen-glucose deprivation by upregulating NRF-2 (Zhang et al., 2019). |
14) hsa-miR-98-5p |
Reduces endothelial dysfunction, protects blood-brain barrier, and improves neurological outcomes after brain injury (Bernstein et al., 2020). |
15) hsa-miR-10a-5p |
Regulates brain-derived neurotrophic factor expression (Zhang et al., 2020a) |
16) hsa-miR-30a-3p |
Loss of miR-30a-3p after controlled cortical injury in rats induces neuropathic pain via elevated E-cadherin transcriptional activator enhancing BDNF (Tan et al., 2020). |
17) hsa-miR-30e-5p |
Targets the 3'UTR region of Nlrp3 to negatively regulate Nlrp3 mRNA and protein expression (Li et al., 2018). |
18) hsa-miR-30d-5p |
Inhibits autophagy-mediated microglial polarization into M1 phenotype (Jiang et al.,2018). |
19) hsa-miR-30e-3p |
Targets the 3'UTR region of Nlrp3 to negatively regulate Nlrp3 mRNA and protein expression (Li et al., 2018). |
20) hsa-miR-30a-5p |
Targets MAPK/ERK pathway and ameliorates inflammatory injury (Fu et al., 2018). |